Atlas Trials

A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna™ Gene Signature Assay

Clinical trial NCT01974856 · COMPLETED

Trial details

NCT number
NCT01974856
Sponsor
NanoString Technologies, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2013-10-01
Primary completion
2014-10-01
Enrollment
201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.